World Investment Advisors Has $6.32 Million Position in Zoetis Inc. (NYSE:ZTS)

World Investment Advisors lifted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 13.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,793 shares of the company’s stock after buying an additional 4,557 shares during the period. World Investment Advisors’ holdings in Zoetis were worth $6,320,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of ZTS. Howard Capital Management Group LLC increased its position in shares of Zoetis by 0.8% during the 3rd quarter. Howard Capital Management Group LLC now owns 104,866 shares of the company’s stock worth $20,489,000 after purchasing an additional 883 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Zoetis by 17.3% during the third quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company’s stock worth $464,497,000 after buying an additional 351,372 shares during the last quarter. Integrated Wealth Concepts LLC raised its position in Zoetis by 1.3% during the third quarter. Integrated Wealth Concepts LLC now owns 7,271 shares of the company’s stock worth $1,421,000 after acquiring an additional 92 shares in the last quarter. Resurgent Financial Advisors LLC acquired a new stake in Zoetis in the third quarter valued at $211,000. Finally, Royal London Asset Management Ltd. grew its position in shares of Zoetis by 4.8% in the 3rd quarter. Royal London Asset Management Ltd. now owns 212,693 shares of the company’s stock valued at $41,556,000 after acquiring an additional 9,746 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several research analyst reports. Barclays upped their price objective on Zoetis from $242.00 to $244.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. UBS Group started coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective for the company. Stifel Nicolaus dropped their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. StockNews.com raised shares of Zoetis from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Finally, Piper Sandler increased their price target on shares of Zoetis from $200.00 to $205.00 and gave the company an “overweight” rating in a report on Thursday, February 27th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Zoetis currently has an average rating of “Buy” and a consensus price target of $215.90.

Zoetis Stock Down 2.5 %

NYSE ZTS opened at $159.34 on Friday. The business has a fifty day moving average price of $166.04 and a two-hundred day moving average price of $173.88. The stock has a market capitalization of $71.35 billion, a PE ratio of 29.13, a PEG ratio of 2.78 and a beta of 0.92. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.33. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.75 and a quick ratio of 1.08.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The business had revenue of $2.32 billion for the quarter, compared to analyst estimates of $2.30 billion. Equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s payout ratio is 36.56%.

Insider Transactions at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of the company’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $170.00, for a total value of $55,420.00. Following the sale, the executive vice president now owns 15,781 shares in the company, valued at approximately $2,682,770. The trade was a 2.02 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Willie M. Reed sold 1,210 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $166.14, for a total transaction of $201,029.40. Following the sale, the director now directly owns 11,245 shares of the company’s stock, valued at $1,868,244.30. This represents a 9.71 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,862 shares of company stock worth $312,254. Insiders own 0.16% of the company’s stock.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.